Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Translational stroke research in the developing brain.

Zinaida S Vexler1, Frank R Sharp, Giora Z Feuerstein

  • 1Department of Neurology, University of California San Francisco, San Francisco, California 94143-0663, USA. zinaida@atsa.ucsf.edu

Pediatric Neurology
|June 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MRI, Child Opportunity Index, and 4-year cognitive outcome after neonatal encephalopathy.

Developmental medicine and child neurology·2026
Same author

Hypoxanthine-early biomarker of outcomes in an ovine model of neonatal hypoxic ischemic encephalopathy.

Pediatric research·2026
Same author

Systematic review of terminology, definitions, and eligibility criteria in trials of neonatal encephalopathy, hypoxic-ischemic encephalopathy, and perinatal asphyxia.

Pediatric research·2026
Same author

ARG1 Inhibition after Neonatal Hypoxic-Ischemic Brain Injury.

Developmental neuroscience·2026
Same author

Temporal and Spatial Gene Expression Dynamics in Neonatal HI Hippocampus with Focus on Arginase.

Cells·2026
Same author

Early peripheral blood gene expression predicts 90-day outcomes following subarachnoid hemorrhage.

Journal of neuroinflammation·2025
Same journal

Corrigendum to Temporary Pacemaker in a Pediatric Guillain-Barré Case With Life-Threatening Bradyarrhythmia Pediatr Neurol 177 (2026) 109-110. doi: 10.1016/j.pediatrneurol.2026.01.015.

Pediatric neurology·2026
Same journal

Clinical Symptoms in Late Infantile and Juvenile Onset Neuronal Ceroid Lipofuscinosis Type 7 (CLN7 Disease).

Pediatric neurology·2026
Same journal

Examining Epilepsy in Angelman Syndrome: Insights From Caregiver-Reported Data in the Linking Angelman and Dup15q Data for Expanded Research Database.

Pediatric neurology·2026
Same journal

Impact of Postpandemic Pediatric Infection Rebound on Febrile Seizures: A Nationwide Cohort Study, 2013-2023.

Pediatric neurology·2026
Same journal

The Hidden Cost of Developmental and Epileptic Encephalopathy in Australia: Caregiver Quality of Life, Sleep, Depression, and Workforce Participation.

Pediatric neurology·2026
Same journal

A Novel Neonatal Brain Injury Score for Infants With Congenital Diaphragmatic Hernia.

Pediatric neurology·2026
See all related articles

Developing age-appropriate preclinical models is crucial for pediatric and newborn stroke clinical trials. Current models highlight age-related brain differences in susceptibility to injury and cell death, informing future trial design.

Area of Science:

  • Neuroscience
  • Pediatric Neurology
  • Stroke Research

Background:

  • Preclinical animal models are essential for advancing clinical trials in pediatric and newborn stroke.
  • Existing models of hypoxia-ischemia and focal stroke reveal limitations in addressing age-specific brain vulnerabilities.

Purpose of the Study:

  • To emphasize the necessity of age-appropriate preclinical models for pediatric and newborn stroke research.
  • To highlight age-related differences in immature brain responses relevant to stroke pathogenesis.

Main Methods:

  • Review of existing preclinical animal models for pediatric and newborn stroke.
  • Analysis of age-dependent susceptibility to oxidative stress and inflammation in the immature brain.
  • Evaluation of age-related differences in apoptotic neuronal death.

Related Experiment Videos

Main Results:

  • Current preclinical models indicate a need for age-specific designs to accurately reflect pediatric and newborn stroke.
  • Immature brains exhibit distinct vulnerabilities to oxidative stress and inflammatory processes compared to adult brains.
  • The rate and extent of neuronal apoptosis vary significantly with age in response to ischemic injury.

Conclusions:

  • Age-appropriate preclinical models are critical for the successful design and execution of pediatric and newborn stroke clinical trials.
  • Understanding age-related differences in brain injury mechanisms is paramount for improving therapeutic strategies.
  • Future clinical trial designs must incorporate these age-specific biological factors to enhance efficacy and safety.